Skip to main content
  • COVID-19
    • COVID-19 vaccines and cancer
      • FAQs
      • FAQs in-language
      • SerOzNET Study
    • COVID-19 information for people affected by cancer
      • Managing your cancer care in the context of COVID-19
      • Looking after your mental wellbeing
      • Canada
      • Ireland
      • UK
      • USA
    • COVID-19 information for children and young people with cancer
    • Cancer Won’t Wait
    • Cancer and COVID-19 - what it means for our Mob
      • COVID-19 vaccines: Information for Aboriginal and Torres Strait Islander people affected by cancer
      • Act early for our Mob's health
    • Guidance for health professionals
      • Diagnosis
      • Treatment
      • Surgery
      • Medical oncology
      • Radiation oncology
      • Primary care
      • Telehealth
      • Clinical trials
      • Follow-up care
      • Supportive and Palliative care
      • Cancer care for cancer patients with COVID-19
      • COVID-19 vaccines and cancer
      • Recovery
    • Research articles
      • Review articles
      • Data articles
      • Recommendations articles
      • Shared experience articles
      • COVID-19 vaccines and cancer articles
    • Cancer care in the time of COVID-19: A conceptual framework
    • Optimal cancer care during the COVID-19 pandemic: the Principles
    • The impact of COVID-19 on cancer services
    • COVID-19 Recovery: Implications for cancer care
      • Expanded use of telehealth
      • Changes to prevention and early detection
      • Virtual multidisciplinary team meetings
      • Modifications to treatment schedules
      • Hypofractionated radiotherapy
      • Oncology hospital in the home
      • Responsive patient support
      • Innovative care and hospital infrastructure models
      • Shared follow-up and survivorship care
      • Supportive and palliative care
      • Cancer research and clinical trials
      • Collaboration in the oncology sector and data sharing
      • Acknowledgements
  • About us
    • Organisational structure
    • Accountability and reporting
      • Annual reports
    • Who we work with
      • Roles & functions
      • Advisory Council
      • Advisory groups
      • Consumer engagement
      • Government cancer control organisations
    • Information publication scheme
      • Information publication scheme plan
      • Freedom of information act
        • The FOI request process
      • FOI disclosure log
    • Reconciliation action plan
    • Employment opportunities
  • News and media
    • News
    • Subscribe to our eNewsletter
  • Contact us
Cancer Australia
Choose Language
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • العربية
  • 简体中文
  • 繁體中文
  • Ελληνικά
  • हिन्दी
  • Italiano
  • 한국어
  • Español
  • Tagalog
  • Tiếng Việt
  • Home
  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives
  • Home
  • Cancer types
    • Bladder cancer
    • Bowel cancer
    • Brain cancer
    • Breast cancer
    • Breast cancer in men
    • Breast cancer in young women
    • Cervical cancer
    • Children’s cancer
    • Endometrial cancer
    • Fallopian cancer
    • Gestational trophoblastic disease
    • Gynaecological cancers
    • Head and neck cancer
    • Kidney cancer
    • Leukaemia
    • Liver cancer
    • Lung cancer
    • Lymphoma
    • Melanoma
    • Mesothelioma cancer
    • Myeloma
    • Neuroendocrine tumours
    • Oesophageal cancer
    • Ovarian cancer
    • Pancreatic cancer
    • Prostate cancer
    • Sarcoma
    • Stomach cancer
    • Testicular cancer
    • Thyroid cancer
    • Unknown primary cancer
    • Uterine sarcoma
    • Vaginal cancer
    • Vulvar cancer
  • Impacted by Cancer
    • What is cancer
    • Physical changes
    • Treatment
    • Keeping healthy
    • Emotions
    • Family and relationships
    • Living with cancer
    • Lynch Syndrome
  • Awareness
    • Your cancer risk
    • Screening
    • Interactive body map
  • Research
    • Cancer Research in Australia
    • Data and statistics
    • Australian Clinical Trials
    • Support for cancer clinical trials
    • Grants and funding
  • Resources
    • Cancer Australia Publications
    • Clinical Practice Guidelines
    • Position statements
    • Resources in other languages
    • Cancer Australia websites
    • Cancer risk online assessment tools
    • Other tools and resources
    • Podcasts
    • Cancer support organisations
    • Glossary
  • Clinicians hub
    • GP guides and resources
    • Guidelines by cancer type
    • Optimal Care pathways
    • Working with Aboriginal and Torres Strait Islander people
    • Multidisciplinary care
    • Psychosocial care
    • Follow-up care
    • Family cancer clinics
    • Cancer Learning
    • Consumer engagement
  • Key initiatives
    • For Aboriginal and Torres Strait Islander people
    • Australian Cancer Plan
    • Australian Brain Cancer Mission
    • Lung Cancer Screening
    • National Pancreatic Cancer Roadmap
    • Campaigns & events
    • Jeannie Ferris Recognition Award

Sarcoma

sarcoma-mm cancer-types/sarcoma/overview
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
    • Home
    • Types
    • Statistics
    • Risk factors
    • Symptoms
    • Diagnosis
    • Treatment
    • Finding support
    • Clinical trials
    • Health professionals
  1. Home
  2. Types
Loading...

Types of sarcoma

  • Printer-friendly version
  • A|A

Soft tissue sarcoma

Soft tissue sarcomas develop in soft tissues such as fat, muscle, blood vessels, lymphatic vessels, nerves, tendons and cartilage.

There are more than 50 types of soft tissue sarcoma.

In adults, the most common types of soft tissue sarcoma are:

  • undifferentiated pleomorphic sarcoma (UPS) – an aggressive type of soft tissue sarcoma that often spreads, or comes back after treatment. It is most common in people aged 50–70 years
  • leiomyosarcoma – a tumour in the smooth muscle, often in the limbs, abdomen or uterus
  • liposarcoma – a tumour in fat cells, often in the trunk, limbs and abdomen
  • angiosarcoma – a tumour in the blood vessels or lymphatic vessels
  • malignant peripheral nerve sheath tumour – a tumour in the lining of nerves, often in the deep tissue of the arms, legs and trunk
  • fibroblastic sarcoma (fibrosarcoma) – a tumour that develops in the fibrous tissues of the body, often in the limbs, skin and trunk
  • gastrointestinal stromal tumour (GIST) – a tumour that starts in the digestive tract, often in people aged 50–80 years. This type of tumour is treated differently to other soft tissue sarcomas
  • Kaposi sarcoma – a tumour caused by a virus that can cause disease in people with a compromised immune system, such as people with AIDS. It most commonly affects the skin, mouth and internal organs
  • uterine sarcoma.

In children, the most common types of soft tissue sarcoma are:

  • rhabdomyosarcoma – an aggressive type of sarcoma in skeletal muscles. Rhabdomyosarcomas are most common in children aged less than 10 years, although they can also develop in teenagers and adults
  • synovial sarcoma – a tumour that develops in cells around joints and tendons. It is more common in children and young adults, but can occur in older people.

Primary bone sarcoma

Primary bone sarcoma starts in the bone. This is different from bone metastases, which have spread to the bones from cancer in another part of the body, such as the breast or lung.

Bone sarcomas are more common in children and teenagers than in older adults. They include:

  • osteosarcoma – the most common primary bone cancer, which usually occurs at the ends of the long bones, especially around the knees
  • Ewing sarcoma – common sites are the pelvis, the chest wall and the middle of the long bones in the legs. It may also form in soft tissue.
  • Last Updated
  • References
  • Relevant Links
updated: 30 December 2022 - 2:40pm

Cancer Council, Soft tissue sarcoma

Cancer Council, Bone cancer

Cancer Australia, Children’s cancer – bone tumours

Cancer Australia, Children’s cancer – soft tissue sarcoma

Australasian Gastro-Intestinal Trials Group and the GI Cancer Institute, Gastro-Intestinal stromal tumour (GIST)

National Cancer Institute (US), Adult Soft Tissue Sarcoma Treatment (PDQ®) – Patient Version

National Cancer Institute (US), Kaposi Sarcoma Treatment (PDQ®) – Patient Version

National Cancer Institute (US), Ewing Sarcoma Treatment (PDQ®) – Patient Version

National Cancer Institute (US), Gastrointestinal Stromal Tumors Treatment (Adult) (PDQ®) – Patient Version

National Cancer Institute (US), Osteosarcoma Treatment (PDQ®) – Patient Version

National Cancer Institute (US), Childhood Soft Tissue Sarcoma Treatment (PDQ®) – Patient Version

National Cancer Institute (US), Childhood Rhabdomyosarcoma Treatment (PDQ®) – Patient Version

National Cancer Institute (US), Childhood Vascular Tumors Treatment (PDQ®) – Patient Version

Related information

What is cancer?
What is cancer?

Cancer is a disease of the cells, which are the body’s basic building blocks.

Treatment and side effects
Treatment and side effects

The treatment that your doctors recommend will depend on the type of cancer you have, how advanced it is, and other personal factors.

Living with cancer
Living with cancer

A diagnosis of cancer marks the beginning of a journey full of emotional, psychological, physical and practical challenges.

Life after cancer
Life after cancer

While looking forward to finishing their cancer treatment and getting on with life, for some people, the end of treatment can also be a confusing or worrying time.

A-Z List of Cancer Types

Information on more than 70 types of cancer

  • Bladder cancer
  • Bowel cancer
  • Brain cancer
  • Breast cancer
  • Breast cancer in men
  • Breast cancer in young women
  • Cervical cancer
  • Children's Cancer
  • Endometrial cancer
  • Fallopian cancer
  • Gestational trophoblastic disease
  • Gynaecological cancers
  • Head and neck cancer
  • Kidney cancer
  • Leukaemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Melanoma of the skin
  • Mesothelioma cancer
  • Myeloma
  • Neuroendocrine tumours
  • Oesophageal cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Sarcoma
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Unknown primary
  • Uterine sarcoma
  • Vaginal cancer
  • Vulval cancer

About Cancer Australia

Cancer Australia was established by the Australian Government in 2006 to benefit all Australians affected by cancer, and their families and carers. Cancer Australia aims to reduce the impact of cancer, address disparities and improve outcomes for people affected by cancer by leading and coordinating national, evidence-based interventions across the continuum of care.

If you would like an interpreter to help you understand any information on this website, please call TIS National on 131 450 and ask them to call Cancer Australia on 02 9357 9400. Our business hours are 9am to 5pm, Monday to Friday.

Freecall 1800 624 973
+61 2 9357 9400

Locked Bag 3, Strawberry Hills
NSW 2012

Navigation

  • Cancer types
  • Impacted by Cancer
  • Awareness
  • Research
  • Resources
  • Clinicians hub
  • Key initiatives

Contact us

* Denotes mandatory fields
 

By submitting this form, you accept the Cancer Australia privacy policy.

  • Contact Us
  • Copyright
  • Disclaimer
  • Privacy policy
  • Sitemap
Copyright © 2023 - Cancer Australia